Viewing nowNewtor 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

MFDS item code 201403432 · Approved 2014.07.28 · Insurance code 669906010
Improvement of hyperlipidemia (including familial hypercholesterolemia in children) and prevention of cardiovascular disease
This medication helps reduce the risk of cardiovascular diseases. In particular, it decreases the risk of myocardial infarction and stroke in adults with risk factors for coronary artery disease and in patients with type 2 diabetes, and also lowers the risks of revascularization procedures and chronic stable angina. For patients already diagnosed with coronary artery disease, it has effects in reducing the risks of non-fatal myocardial infarction, stroke, revascularization, hospitalization for congestive heart failure, and angina. Furthermore, this medication lowers total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels in patients with hyperlipidemia while increasing levels of HDL-cholesterol, the 'good' cholesterol. It is particularly beneficial for patients with familial hypercholesterolemia and those with dyslipidemia that is not controlled solely by diet. It is used not only for adults but also for patients aged 10-17 years who meet the criteria for hypercholesterolemia to control their cholesterol levels.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of more than 45 % is required). This medicine is administered at doses ranging from 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks of initiation of treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing response. If LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg in pediatric patients).
This medication may cause muscle-related symptoms, so if muscle pain, weakness, or cramping occurs, consult a doctor immediately. In particular, it should be discontinued if there is a significant increase in muscle enzyme levels or suspicion of myopathy. Caution is required if there is liver disease or if liver function test results are abnormally high as this medication may affect liver function. Women who are pregnant or may become pregnant should not take this medication, and adequate contraception should be used during treatment. Nursing women should also avoid taking this medication. This medication may interact with certain drugs, so inform your doctor or pharmacist if you are taking other medications. Elderly patients or those with impaired kidney function should use caution due to a higher risk of muscle problems. If symptoms such as malaise, fever, or muscle pain appear during treatment, notify healthcare personnel immediately. This medication contains lactose, so patients with lactose intolerance should not take it. Children, especially those under the age of 10, should not use this medication. Always follow the prescribed dosage and administration method, and do not arbitrarily stop or change the dose. Store the medication out of reach of children and keep it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is also advisable to store the medication at room temperature between 1 and 30 degrees Celsius. This way of storage will help maintain the medication’s efficacy and allow safe usage.
White oval film-coated tablet
For domestic use - 30 tablets/bottle, for domestic use - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.